H
Hui Chen
Researcher at Soochow University (Suzhou)
Publications - 10
Citations - 551
Hui Chen is an academic researcher from Soochow University (Suzhou). The author has contributed to research in topics: Intensive care & Medicine. The author has an hindex of 4, co-authored 6 publications receiving 323 citations.
Papers
More filters
Journal ArticleDOI
Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19.
Yang Wang,Xiaofan Lu,Yongsheng Li,Hui Chen,Taige Chen,Nan Su,Fang Huang,Jing Zhou,Bing Zhang,Fangrong Yan,Jun Wang +10 more
TL;DR: Clinical characteristics and outcomes of intensive care patients, data on whom are scarce but are of paramount importance to reduce mortality, are focused on.
Journal ArticleDOI
A simple nomogram for predicting failure of non-invasive respiratory strategies in adults with COVID-19: a retrospective multicentre study.
Ling Liu,Jianfeng Xie,Wenjuan Wu,Hui Chen,Shusheng Li,Hongli He,Yuetian Yu,Ming Hu,Jinxiu Li,Ruiqiang Zheng,Xuyan Li,Haibo Qiu,Zhaohui Tong,Bin Du,Eddy Fan,Yi Yang,Arthur S. Slutsky +16 more
TL;DR: Wang et al. as discussed by the authors used a multivariable logistic regression and concordance statistics (C-statistics) to identify early predictors of NIRS failure, defined as subsequent need for IMV or death within 28 days after intensive care unit admission.
Journal ArticleDOI
Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Patients With COVID-19 With Hyperinflammatory Phenotype.
Hui Chen,Jianfeng Xie,Nan Su,Jun Wang,Qin Sun,Shusheng Li,Jun Jin,Jing Zhou,Min Mo,Yao Wei,Yali Chao,Weiwei Hu,Bin Du,Haibo Qiu +13 more
TL;DR: For critically ill patients with COVID-19, corticosteroid therapy was not associated with 28-day mortality, but the use of corticosticosteroids showed significant survival benefits in patients with the hyperinflammatory phenotype.
Journal ArticleDOI
Dynamic APACHE II Score to Predict the Outcome of Intensive Care Unit Patients
TL;DR: Day-3 APACHE II score is an optimal biomarker to predict the outcomes of ICU patients; 17 is the best cut-off for defining patients at high risk of mortality.
Journal ArticleDOI
Simplified immune-dysregulation index: a novel marker predicts 28-day mortality of intensive care patients with COVID-19.
TL;DR: The proposed simplified Immune-dysregulation Index predicts 28-day mortality of intensive care patients with COVID-19, a novel marker that significantly reduces the uncertainty in the prognosis of prior studies of this type.